Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05027867
Title KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Kartos Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | AUS

Additional content available in CKB BOOST